Edwards Lifesciences (EW) Announces CEO Succession Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Edwards Lifesciences (EW) PT Lowered to $85 at Truist Securities
December 9, 2022 7:32 AM ESTTruist Securities analyst Richard Newitter lowered the price target on Edwards Lifesciences (NYSE: EW) to $85.00 (from $95.00) while maintaining a Buy rating.
The analyst commented, "While a planned CEO transition does add a new factor, EW's NYC I-Day is unlikely to sway the... More
